30 closest matches · ranked by relevance
Diastolic Heart Failure · Hypertensive Heart Disease
Primary: Brachial Artery Flow-mediated Dilation (FMD) — 5; 8 % dilation — p=.17
Renal Dialysis
Primary: Time Specific Interdialytic Weight Gain (Baseline) — 1.2; 1.2 kg/day
Rheumatoid Arthritis
Primary: Change in Tissue Sodium — 17.1; 16.7 mmol/L — p=0.55
Hypertension
Primary: Mean 24 Hour Ambulatory Systolic Blood Pressure (MASBP) in Systolic Hypertensive Patients Treated With Aliskiren (300 mg) for 4 Weeks on a High Sodium Diet Versus 4…
Hypertension
Primary: Improved Flow Mediated Dilation — 3.57; 6.01 percentage dilation
Diet, Sodium-Restricted · Heart Failure C14.280.434
Primary: Difference in Mean Milligrams of Dietary Sodium in Chosen Foods Pre- and Post- Color Coded Cue Card Intervention — 173.78 milligrams
Hypertension · Physical Disability · Aging
Primary: Seated Blood Pressure — 112.1; 116.1; 60.3; 60.4 mmHg
Postural Orthostatic Tachycardia Syndrome
Primary: Plasma Volume — 2805; 3032; 2362; 2633 mL
Diabetes Mellitus, Type 2 · Diabetes · Diabetes type2
Primary: Systolic Blood Pressure (SBP) — 122.4; 127.2; 124.8; 127.0 mmHg — p=<0.001
Hypertension
Primary: Number of Patients Achieving Target Blood Pressure at Week 14 From Baseline — 276; 270; 116; 87 Participants — p=0.118
Hypertension · Chronic Kidney Disease · Microalbuminuria
Primary: ∆Albuminuria by 24-hour Urine Protein Excretion — 483.5; 569.9; 487.3; 417.4 mg/day — p=0.006
Postural Orthostatic Tachycardia Syndrome
Primary: 24hr Urinary Sodium — 16.8; 280; 14.7; 245 milliequivalents
Heart Failure
Primary: Patients' Adherence to Sodium-restricted Diet Assessed by Urinary Sodium Excretion Levels — 4390.2; 4048.9; 3338.1; 4402.9 mg/day
Cardiovascular Disease
Primary: Mean Change in Vascular Function Measured by Pulse Wave Velocity — 7.08; 7.13; 7.34; 7.07 m/s — p=0.98
Heart Failure
Primary: Carotid-femoral Pulse Wave Velocity — -0.3; 0.4 m/s — p=0.28
Diabetes Mellitus · Diabetic Kidney Disease · Hypertension
Primary: To Investigate the Modifying Effect of Sodium Intake on Ertugliflozin on Blood Pressure — 125; 121; 138; 133 mmHg — p=0.0174
Hypertension
Primary: Change in Tissue Sodium Concentration Measured Using Sodium Magnetic Resonance Imaging (NaMRI) — -0.202; 0.430; -1.745; -0.407 mmol/L
Postural Tachycardia Syndrome (POTS)
Primary: FMD (% Change) — 12.75; 11.65; 11.43; 12.75 percentage of change
Chronic Kidney Diseases · High Blood Pressure
Primary: Number of Group Counseling Sessions Attended by Participants Randomized to the Treatment Arm — 8.9 sessions per participant
Chronic Kidney Disease
Primary: 24-hour Urinary Sodium Excretion — 93; 119 mmol/day
Obesity · Cardiovascular Disease · Metabolic Syndrome
Primary: Weight Loss — -2.1; -3.2; -3.0; -3.3 kg
Hypertension
Primary: 24-hour Urinary Sodium Excretion — 220.58; 198.73; 177.40; 146.18 mmol/24 hours
Kidney Failure, Chronic · Kidney Failure, Acute · Heart Failure
Primary: Number of Participants With Acute Kidney Injury During the First 48 Hours After Contrast Administration — 5; 4 Participants
Chronic Kidney Disease · Hypertension
Primary: Change in Urinary Albumin Excretion From Baseline to 4 Months — -28.6; -5.6 mg/g — p=0.17
Gout · Hyperuricemia
Primary: Uric Acid Level — 8.23; 8.03 mg/dL
Intra-dialytic Hypotension
Primary: Change in Intra-dialytic Decline in Systolic Blood Pressure — 26; 23 mm Hg
Healthy Participants
Primary: Plasma Dopa 1 hr After Breakfast — 11670; 1705 pg/mL
Hypertension
Primary: 24-hour Average Systolic Blood Pressure — 127; 127; 126; 129 mmHg
Hypertension
Primary: Change in 24-hour Mean Systolic Blood Pressure by ABPM From Day 5 of Low Sodium to Day 10 of High Sodium — 7.7; 9.3 mmHg
Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Primary: Change in Mean Serum Copeptin From Baseline (a Reflection of Endogenous Vasopressin Production) at Week 2 — -0.86; 0.39 pmole/L — p=<0.01